View in EDS

Tongmaijiangzhi formula and its hypolipidemic compounds attenuate hyperlipidemia and hepatic steatosis via AMPK/NF-κB pathway.

Saved in:
Bibliographic Details
Title: Tongmaijiangzhi formula and its hypolipidemic compounds attenuate hyperlipidemia and hepatic steatosis via AMPK/NF-κB pathway.
Authors: Xu QN; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China., Yang YX; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China., Chen YJ; Drug Clinical Trial Institution, the First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, 361000, China., He SL; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China., Yang RJ; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China., Zhu CY; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China., Du CC; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China., Zhang DD; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China., Wang GH; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China., Bian YT; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China., Luo X; Drug Clinical Trial Institution, the First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, 361000, China., Wu CS; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China. Electronic address: wucsh@xmu.edu.cn., Tian WJ; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China. Electronic address: tianwj@xmu.edu.cn., Chen HF; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China. Electronic address: haifeng@xmu.edu.cn.
Source: Journal of ethnopharmacology [J Ethnopharmacol] 2026 Feb 28; Vol. 357, pp. 120897. Date of Electronic Publication: 2025 Nov 20.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7573 (Electronic) Linking ISSN: 03788741 NLM ISO Abbreviation: J Ethnopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41274521
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tongmaijiangzhi formula and its hypolipidemic compounds attenuate hyperlipidemia and hepatic steatosis via AMPK/NF-κB pathway.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Xu+QN%22">Xu QN</searchLink>; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.<br /><searchLink fieldCode="AU" term="%22Yang+YX%22">Yang YX</searchLink>; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.<br /><searchLink fieldCode="AU" term="%22Chen+YJ%22">Chen YJ</searchLink>; Drug Clinical Trial Institution, the First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, 361000, China.<br /><searchLink fieldCode="AU" term="%22He+SL%22">He SL</searchLink>; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.<br /><searchLink fieldCode="AU" term="%22Yang+RJ%22">Yang RJ</searchLink>; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.<br /><searchLink fieldCode="AU" term="%22Zhu+CY%22">Zhu CY</searchLink>; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.<br /><searchLink fieldCode="AU" term="%22Du+CC%22">Du CC</searchLink>; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.<br /><searchLink fieldCode="AU" term="%22Zhang+DD%22">Zhang DD</searchLink>; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.<br /><searchLink fieldCode="AU" term="%22Wang+GH%22">Wang GH</searchLink>; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.<br /><searchLink fieldCode="AU" term="%22Bian+YT%22">Bian YT</searchLink>; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.<br /><searchLink fieldCode="AU" term="%22Luo+X%22">Luo X</searchLink>; Drug Clinical Trial Institution, the First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, 361000, China.<br /><searchLink fieldCode="AU" term="%22Wu+CS%22">Wu CS</searchLink>; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China. Electronic address: wucsh@xmu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Tian+WJ%22">Tian WJ</searchLink>; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China. Electronic address: tianwj@xmu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Chen+HF%22">Chen HF</searchLink>; Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China. Electronic address: haifeng@xmu.edu.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227903310%22">Journal of ethnopharmacology</searchLink> [J Ethnopharmacol] 2026 Feb 28; Vol. 357, pp. 120897. <i>Date of Electronic Publication: </i>2025 Nov 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Sequoia%22">Elsevier Sequoia </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>7903310 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7573 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203788741%22">03788741 </searchLink><i>NLM ISO Abbreviation: </i>J Ethnopharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41274521
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jep.2025.120897
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 120897
    Titles:
      – TitleFull: Tongmaijiangzhi formula and its hypolipidemic compounds attenuate hyperlipidemia and hepatic steatosis via AMPK/NF-κB pathway.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Xu QN
      – PersonEntity:
          Name:
            NameFull: Yang YX
      – PersonEntity:
          Name:
            NameFull: Chen YJ
      – PersonEntity:
          Name:
            NameFull: He SL
      – PersonEntity:
          Name:
            NameFull: Yang RJ
      – PersonEntity:
          Name:
            NameFull: Zhu CY
      – PersonEntity:
          Name:
            NameFull: Du CC
      – PersonEntity:
          Name:
            NameFull: Zhang DD
      – PersonEntity:
          Name:
            NameFull: Wang GH
      – PersonEntity:
          Name:
            NameFull: Bian YT
      – PersonEntity:
          Name:
            NameFull: Luo X
      – PersonEntity:
          Name:
            NameFull: Wu CS
      – PersonEntity:
          Name:
            NameFull: Tian WJ
      – PersonEntity:
          Name:
            NameFull: Chen HF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 02
              Text: 2026 Feb 28
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1872-7573
          Numbering:
            – Type: volume
              Value: 357
          Titles:
            – TitleFull: Journal of ethnopharmacology
              Type: main
ResultId 1